Suzette Kox named IGBA's new secretary general

A woman who has been involved in biosimilars since work on their development first began two decades ago, has been named director general of the International Generic and Biosimilar medicines Association (IGBA).

For four years, Suzette Cox has been a senior director of the Biosimilar Medicines Group at Medicines for Europe, one of the members of IGBA, which was founded to strengthen cooperation between associations representing manufacturers of generic and biosimilar medicines from around the world.

Her main role in her new position with the Switzerland-based group will be to coordinate the IGBA activities as the association continues to expand its outreach relevant to its mission, priorities and operations.